Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 6, 2025

Advances in STING Pathway Modulation for Cancer and Immunotherapy: A Comprehensive Review of Preclinical and Clinical Studies (2020-2024).

View Full Paper
Ask AI
Bookmark
Share

Authors

RSRahaman ShaikKSKomal SutharCBChandrika Balija

Discussion

Loading...

Member takes

Overview

Comprehensive review shows sting pathway modulation improves cancer treatment in preclinical and clinical settings, suggesting new therapeutic strategies.

Key Points

  • Main finding indicates that sting pathway modulation can enhance cancer immunotherapy outcomes.
  • Preclinical data reveal that sting agonists effectively convert cold tumors to hot ones, improving immune responses.
  • Innovative delivery systems like nanoparticles enhance the efficacy of sting pathway modulators in treatment.
  • Challenges such as managing immune-related adverse events must be addressed for sting-targeted therapies to succeed.

Cite This Study

Shaik et al. (2025) studied this question.

synapsesocial.com/papers/689a0fa0e6551bb0af8d1805https://doi.org/10.1177/10849785251362585
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1STINGing Cancer: Development, Clinical Application, and Targeted Delivery of STING Agonists2025 · 16 citations
  2. 2The cGAS–STING pathway in cancer immunotherapy: prognostic value and therapeutic potential2026 · 3 citations
  3. 3Unlocking the therapeutic potential of the STING signaling pathway in anti-tumor treatment2025 · 16 citations
  4. 4Nanocarrier-enabled STING agonist delivery for enhanced cancer immunotherapy2025
  5. 5STING-targeting PROTACs: emerging therapeutic tools for enhanced immunotherapy in inflammatory diseases2025